Evidence map›Paper›PMID 25995452›Full record

ArticleThe Journal of biological chemistry2015

Structural Mechanisms of Mutant Huntingtin Aggregation Suppression by the Synthetic Chaperonin-like CCT5 Complex Explained by Cryoelectron Tomography.

Michele C Darrow, Oksana A Sergeeva, Jose M Isas, Jesús G Galaz-Montoya, Jonathan A King, Ralf Langen, Michael F Schmid, Wah Chiu

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 49 citations in OpenAlex.

  1. Chaperonin in health and disease.Molecular biomedicine · 2026
    Review
  2. Article
  3. Missing Wedge Completion via Unsupervised Learning with Coordinate Networks.International journal of molecular sciences · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. The TRiCky Business of Protein Folding in Health and Disease.Frontiers in cell and developmental biology · 2022
    Review
  12. Article
  13. Multi-scale 3D Cryo-Correlative Microscopy for Vitrified Cells.Structure (London, England : 1993) · 2020
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Michele C DarrowFrom the National Center for Macromolecular Imaging, Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030.
Oksana A Sergeevathe Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, and.
Jose M Isasthe Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, California 90033.
Jesús G Galaz-MontoyaFrom the National Center for Macromolecular Imaging, Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030.
Jonathan A Kingthe Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, and.
Ralf Langenthe Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, California 90033.
Michael F SchmidFrom the National Center for Macromolecular Imaging, Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030.
Wah ChiuFrom the National Center for Macromolecular Imaging, Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030, wah@bcm.edu.
Baylor College of Medicine · USMassachusetts Institute of Technology · USUniversity of Southern California · US

Funding

Center for Protein Folding Machinery (RMI)PN2EY016525 · NEI · BAYLOR COLLEGE OF MEDICINE · PI CHIU, WAH · 2005 to 2015
$33.6M
3 D ELECTRON MICROSCOPY OF MACROMOLECULES (5P41RR002250-27)P41GM103832 · NIGMS · STANFORD UNIVERSITY · PI CHIU, WAH · 2012 to 2019
$15.1M
SUPPORT AND DEVELOPMENT OF EMAN FOR ELECTRON MICROSCOPY IMAGE PROCESSINGR01GM080139 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI LUDTKE, STEVEN J · 2006 to 2022
$5.4M
Molecular mechanisms of huntingtin misfoldingR01NS084345 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LANGEN, RALF · 2015 to 2019
$2.2M
NEI NIH HHS PN2 EY016525NEI NIH HHS PN2EY016525NIBIB NIH HHS NIBIB T32EB009270NIGMS NIH HHS P41 GM103832NIGMS NIH HHS P41GM103832NIGMS NIH HHS R01 GM080139NIGMS NIH HHS R01GM080139NINDS NIH HHS R01 NS084345NINDS NIH HHS R01NS084345
6 · The paper itself

Abstract

Huntington disease, a neurodegenerative disorder characterized by functional deficits and loss of striatal neurons, is linked to an expanded and unstable CAG trinucleotide repeat in the huntingtin gene (HTT). This DNA sequence translates to a polyglutamine repeat in the protein product, leading to mutant huntingtin (mHTT) protein aggregation. The aggregation of mHTT is inhibited in vitro and in vivo by the TCP-1 ring complex (TRiC) chaperonin. Recently, a novel complex comprised of a single type of TRiC subunit has been reported to inhibit mHTT aggregation. Specifically, the purified CCT5 homo-oligomer complex, when compared with TRiC, has a similar structure, ATP use, and substrate refolding activity, and, importantly, it also inhibits mHTT aggregation. Using an aggregation suppression assay and cryoelectron tomography coupled with a novel computational classification method, we uncover the interactions between the synthetic CCT5 complex (∼ 1 MDa) and aggregates of mutant huntingtin exon 1 containing 46 glutamines (mHTTQ46-Ex1). We find that, in a similar fashion to TRiC, synthetic CCT5 complex caps mHTT fibrils at their tips and encapsulates mHTT oligomers, providing a structural description of the inhibition of mHTTQ46-Ex1 by CCT5 complex and a shared mechanism of mHTT inhibition between TRiC chaperonin and the CCT5 complex: cap and contain.

Indexed as

Chaperonin Containing TCP-1Cryoelectron MicroscopyElectron Microscope TomographyHumansHuntingtin ProteinHuntington DiseaseModels, MolecularMutant ProteinsNerve Tissue ProteinsProtein AggregatesProtein Aggregation, PathologicalProtein Interaction Domains and MotifsProtein Structure, QuaternaryRecombinant ProteinsCCT5 protein, humanChaperonin Containing TCP-1HTT protein, humanHuntingtin ProteinMutant ProteinsNerve Tissue ProteinsProtein AggregatesRecombinant ProteinsCCT5 complexchaperonincryoelectron microscopyelectron tomographyHuntington diseaseprotein aggregationsingle-particle tomography

Identifiers

PMID25995452
PMCPMC4498080
OpenAlexW1892591662

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.